Los Angeles Capital Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.26M Buy
346,966
+346,302
+52,154% +$6.65M 0.03% 346
2026
Q1
$11.7K Sell
664
-21,501
-97% -$432K ﹤0.01% 1905
2025
Q4
$379K Buy
+22,165
New +$398K ﹤0.01% 1005
2023
Q4
– Sell
-92,369
Closed -$641K – 1125
2023
Q3
$641K Buy
+92,369
New +$557K ﹤0.01% 770
2023
Q1
– Sell
-58,024
Closed -$682K – 1157
2022
Q4
$682K Sell
58,024
-7,673
-12% -$93.3K ﹤0.01% 816
2022
Q3
$778K Buy
+65,697
New +$959K ﹤0.01% 784

Other funds holding ALHC

Los Angeles Capital Management's ALHC Position: Q2 2026 in Review

Los Angeles Capital Management increased its Alignment Healthcare (ALHC) stake by 52,154% in Q2 2026, buying an estimated $6.65M and bringing the position to 346,966 shares worth $8.26M. The position accounts for 0.03% of the portfolio, ranked #346.

Los Angeles Capital Management first reported a position in ALHC in Q3 2022 and has held it in 6 quarters since. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Los Angeles Capital Management held 346,966 shares of Alignment Healthcare worth $8.26M as of Q2 2026.
  • Los Angeles Capital Management bought 346,302 Alignment Healthcare shares in Q2 2026, an estimated $6.65M.
  • Alignment Healthcare made up 0.03% of Los Angeles Capital Management's portfolio in Q2 2026, its #346 holding.
  • Los Angeles Capital Management first reported a position in Alignment Healthcare in Q3 2022 and has held it in 6 quarters since.
  • 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.